iRhythm Technologies, Inc. (NASDAQ: IRTC) had its price target raised by analysts at Truist Financial Co. from $85.00 to $111.00. They now have a "buy" rating on the stock.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Reach Out
Wearable Medication Adherence Tracker Market Size Worth US$ 6,404.8 Million at a CAGR of 10.3% by 2034 | Fact.MR Report [Yahoo! Finance]
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Connect